GlassScriptPhysician profile
Katherine M Baker
NPI 1891068896
$4,564.07
in general payments reported to CMS, 2019-2025
20 companies · $659 in 2025
The $659 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $1,301 · 2023: $2,211 · 2024: $173 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,804 · Food and Beverage: $1,147 · Education: $91.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,803.88 |
| Food and Beverage | $1,146.69 |
| Education | $91.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $2,246.04 | 2022-2023 | Reactiv8 |
| Axonics, INC. | $1,069.51 | 2023 | Axonics |
| Janssen Biotech, INC. | $224.50 | 2025 | Erleada, Carvykti, Rybrevant |
| Vertos Medical, INC. | $198.78 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $112.86 | 2023 | Pylarify |
| Amgen INC. | $105.39 | 2021 | |
| Lilly USA, LLC | $91.70 | 2024 | Jaypirca |
| Medtronic, INC. | $77.78 | 2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $65.38 | 2025 | |
| Coloplast Corp | $52.64 | 2025 | |
| Sumitomo Pharma America, INC. | $47.42 | 2024-2025 | Orgovyx |
| Abbott Laboratories | $43.26 | 2025 | Freestyle Libre |
| Boston Scientific Corporation | $38.36 | 2025 | Lithovue |
| Ge Healthcare | $36.30 | 2024 | |
| Ferring Pharmaceuticals INC. | $33.42 | 2025 | Adstiladrin |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $30.99 | 2025 | Barrigel |
| Vertex Pharmaceuticals Incorporated | $23.59 | 2025 | |
| Procept Biorobotics Corporation | $22.93 | 2025 | |
| Telix Pharmaceuticals | $22.71 | 2025 | Illuccix |
| Ecs Opco 1 LLC | $20.51 | 2024 | Antimicrobial Catheters |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.